Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valtrex for Suppression of HSV-2 Genital Herpes
NCT00158860Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2004
- Primary completion
- Jul 2006
- Modality
- Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
Phase 4, randomised, double-blind trial in genital herpes comparing Valaciclovir with Placebo (2 arms). Primary endpoint: Percentage of Participants With Time to First GH Recurrence at Day 168. Started Jun 2004; status: completed.
02
Drugs
valaciclovir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00158860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158860.